Trials / Recruiting
RecruitingNCT06580860
Psychiatric Multi-omics and Neuroimaging Project
Psychiatric Multi-omics and Neuroimaging Project Database
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,899 (estimated)
- Sponsor
- mingjun Zhong · Academic / Other
- Sex
- All
- Age
- 13 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.
Detailed description
The study seeks to identify possible biological markers of schizophrenia and the effects of gene-environment interactions on brain structural and functional networks. So we can help doctors and scientific researchers better understand the neuropathological basis of schizophrenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids | Patients with mental disorders should take the appropriate medicine as prescribed by the doctor,and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2024-08-30
- Last updated
- 2026-03-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06580860. Inclusion in this directory is not an endorsement.